24СʱÈÈÃŰæ¿éÅÅÐаñ    

Znn3bq.jpeg
²é¿´: 630  |  »Ø¸´: 3
±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

ÕÜÄý

ľ³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúĬ¿ËË÷ÒýÏà¹ØÐÅÏ¢£¬Ð»Ð»´ó¼Ò

ÇóÖúĬ¿ËË÷ÒýÏà¹ØÐÅÏ¢£¬Ð»Ð»´ó¼Ò£¬¿É×·¼Ó½ð±Ò£º

Ó¢ÎÄͨÓÃÃû£ºIxabepilone
ÖÐÎÄͨÓÃÃû£ºÒÁɳƥ¡
ÉÌÆ·Ãû£º Ixempra
CASµÇ¼ºÅ£º219989-84-1
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

leyi1504

½ð³æ (СÓÐÃûÆø)

ÓÐÈÛµãºÍ¾§Ð͵ÄÐÔÖÊÂð~~¸Ðл
stayhungrey,stayfoolish.
4Â¥2014-03-04 15:04:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ÕÜÄý: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, лл 2013-09-16 22:22:52
jssxh: ½ð±Ò+3, ¼ìË÷EPI+1, лл²ÎÓ룬Çë¼ÌÐø¹Ø×¢±¾°æ¿é£¡ 2014-03-05 11:48:12
Title: Ixabepilone
CAS Registry Number: 219989-84-1
CAS Name: (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
Additional Names: azaepothilone B
Manufacturers' Codes: BMS-247550; NSC-710428
Molecular Formula: C27H42N2O5S
Molecular Weight: 506.70
Percent Composition: C 64.00%, H 8.35%, N 5.53%, O 15.79%, S 6.33%
Literature References: Microtubule stabilizing semisynthetic lactam analog of epothilone B, q.v. Prepn: G. D. Vite et al., WO 9902514; eidem, US 6605599 (1999, 2003 both to Bristol-Myers Squibb); R. M. Borzilleri et al., J. Am. Chem. Soc. 122, 8890 (2000). Antineoplastic activity in vitro and in vivo: F. Y. F. Lee et al., Clin. Cancer Res. 7, 1429 (2001). Clinical evaluation with estramustine in prostate cancer: J. E. Rosenberg et al., Cancer 106, 58 (2006). Clinical pharmacokinetics and evaluation in solid tumors: S. Mani et al., Clin. Cancer Res. 10, 1289 (2004). Clinical evaluation in breast cancer: J. A. Low et al., J. Clin. Oncol. 23, 2726 (2005); in prostate cancer: M. Hussain et al., ibid. 8724. Review of pharmacology and clinical development: N. Lin et al., Curr. Opin. Invest. Drugs 4, 746-756 (2003).
Properties: Colorless oil or white lyopholizate; [a]D22 -40.7¡ã (c = 1.0 in chloroform).
Optical Rotation: [a]D22 -40.7¡ã (c = 1.0 in chloroform)
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Alkaloids/Natural Products.
2Â¥2013-09-16 22:05:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÕÜÄý

ľ³æ (СÓÐÃûÆø)

ÕÜÄý: »ØÌûÖö¥ 2013-09-16 22:27:23
ÒýÓûØÌû:
2Â¥: Originally posted by baiyuefei at 2013-09-16 22:05:41
Title: Ixabepilone
CAS Registry Number: 219989-84-1
CAS Name: (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3--17-oxa-4-azabicycloheptadecane-5,9-dione
Additional Names: azaep ...

ллÄ㣬Õâ¸öÓл¯ºÏÎïµÄÀí»¯ÐÔÖÊÂð£¿Ã»Ê±¼ä×Ô¼ºÕÛÌÚĬ¿ËÁË£¬¿É×·¼Ó½ð±Ò
3Â¥2013-09-16 22:24:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[˶²©¼ÒÔ°] ÓÐûÓÐѧУ²ÄÁÏרҵÊÕ¿çµ÷(Ò»Ö¾Ô¸085410) +9 momo(Éϰ¶°æ) 2026-04-06 12/600 2026-04-13 10:48 by 686666
[¿¼ÑÐ] һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á +5 Ľ¾øcc 2026-04-09 5/250 2026-04-13 09:15 by boborun
[¿¼ÑÐ] 086000µ÷¼Á +6 Ê®Æßsa 2026-04-07 6/300 2026-04-12 11:05 by ´óÁ¦Ë®ÊÖÁ¦´óÎÞÇ
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎ288·Ö£¬ÈýÄêʵÑé¾­Àú +11 ´úfish 2026-04-09 11/550 2026-04-12 10:21 by Hayaay
[¿¼ÑÐ] 316Çóµ÷¼Á +5 Ïë¶ÁÑо¿Éú( ?¡ß 2026-04-07 5/250 2026-04-12 00:43 by À¶ÔÆË¼Óê
[½Ìʦ֮¼Ò] ÇëÎʵØÀí¡¢Ò£¸Ð·½Ã棬¿ÉÒÔ×öÄÄЩºáÏòÏîÄ¿°¡£¬×ÝÏòÍê²»³É¿¼ºË°¡ +3 ½õÒÂÎÀº®Õ½ 2026-04-07 5/250 2026-04-11 20:51 by Ô¥½·
[¿¼ÑÐ] 11408¡£358Çóµ÷¼Á +3 TMYzds 2026-04-07 3/150 2026-04-11 17:10 by µªÆøÆøÆø
[¿¼ÑÐ] 352 Çóµ÷¼Á +6 yzion 2026-04-11 8/400 2026-04-11 16:24 by Ã÷Ô´ËʱÓÐ
[¿¼ÑÐ] 0859£¬337Çóµ÷¼Á +4 ÑÐs. 2026-04-10 4/200 2026-04-11 11:34 by caotw2020
[¿¼ÑÐ] 300·ÖÇóµ÷¼Á £¨085501»úеר˶£¬±¾¿ÆÑï´ó£© +8 xu@841019 2026-04-11 8/400 2026-04-11 10:46 by qingpingzhu
[¿¼ÑÐ] 298Çóµ÷¼Á +9 ¶¤¶£ß˶¬¹Ï 2026-04-07 11/550 2026-04-11 09:35 by zhq0425
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«±±´óѧ¿ØÖƹ¤³Ì085406Êý¶þÓ¢¶þ385£¬Çóµ÷¼Á +8 Ezra_Zhang 2026-04-09 8/400 2026-04-11 09:15 by Öí»á·É
[¿¼ÑÐ] ±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ +11 LZH£¨µÈ´ýµ÷¼ÁÖÐ 2026-04-10 11/550 2026-04-11 08:39 by zhq0425
[¿¼ÑÐ] 342µç×ÓÐÅϢר˶Çóµ÷¼Á +9 ÄãÈÃÎÒÔõôÀóÖ¦ 2026-04-10 10/500 2026-04-11 08:33 by zhq0425
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +17 ŬÁ¦·Ü¶·112 2026-04-06 20/1000 2026-04-11 00:31 by wangjihu
[¿¼ÑÐ] ²ÄÁϹ¤³Ì322 +18 ¹þ¹þ¹þºðºðºð¹þ 2026-04-07 19/950 2026-04-09 10:44 by cymywx
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄÏ´óѧÉúÎïѧѧ˶344 ÇóÉúÎïѧÏà¹Øµ÷¼Á/ÉúÎïÓëÒ½Ò© +7 ³¬È˲»»á·É@ 2026-04-08 7/350 2026-04-09 09:35 by gong120082
[¿¼ÑÐ] ²ÄÁÏ¿¼ÑÐÇóµ÷¼Á×Ü·Ö280 +30 mkjlz1 2026-04-06 35/1750 2026-04-08 21:25 by cyh¡ª315
[¿¼ÑÐ] 263·ÖBÇøÇóµ÷¼Á +6 Àînihao 2026-04-08 6/300 2026-04-08 09:38 by ÄÏ¿ªÐ¡ôë
[¿¼ÑÐ] 316Çóµ÷¼Á +4 15318418673 2026-04-07 4/200 2026-04-07 22:12 by hemengdong
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û